drugset / Trial / NCT03947138
A Study of GC3107(BCG Vaccine) in Healthy Infants
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to investigate the efficacy and safety of GC3107 in healthy infants
Timeline
- Start
- 2019-08-06
- Primary completion
- 2022-06-20
- Completion
- 2022-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BCG SSI | Vaccine | 0.05 ml | Other |
| Subject | GC3107 | Unknown | 0.05 ml | Other |